(lp0
S"POZEN Inc. Stock is Skyrocketing -- Here's Why Motley Fool - Jun 8, 2015 What: Shares of POZEN , a pharmaceutical company focused on developing therapies to treat acute and chronic pain, lifted the pains of its shareholders away this morning by rising as much as 29% following the announcement of an&nbsp;...Pozen buying Canada's Tribute Pharmaceuticals for US$146 million - CanadianBusiness.comPOZEN Announces Strategic Acquisition of Tribute and Growth Capital Commitment ... - Business Wire "
p1
aS"BRIEF-Aralez Pharmaceuticals, units, Pozen Inc filed lawsuit against Teva ... Reuters - Jan 27, 2017 ABERDEEN, Scotland, March 18 Refusal by Britain's prime minister to discuss an independence referendum would &quot;shatter beyond repair&quot; the United Kingdom's constitutional structure, Nicola Sturgeon told her Scottish National Party on Saturday."
p2
aS'Pozen Inc. v. Par Pharmaceutical, Inc.  Patent Docs - Oct 3, 2012 Last week, in Pozen Inc. v. Par Pharmaceutical, Inc., the Federal Circuit affirmed the decision of the U.S. District Court for the Eastern District of Texas that two patents that describe treating migraines by combining two known drugs in a single dose ...'
p3
aS'POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc. PR Newswire  - Feb 5, 2016 MILTON, Ontario, Feb. 5, 2016 /PRNewswire/ -- Aralez Pharmaceuticals Inc.  today announced the completion of the business combination of POZEN Inc.  and Tribute Pharmaceuticals Canada Inc.  following approval of the&nbsp;...POZEN , Tribute Pharma Complete Combination  - StreetInsider.com'
p4
aS'POZEN Appoints Scott Charles Senior Vice President of Finance Business Wire  - Jul 27, 2015 CHAPEL HILL, N.C.----POZEN Inc.  , a pharmaceutical company committed to developing medicine that transforms lives, today announced that Scott Charles will be appointed Senior Vice President of Finance of&nbsp;...'
p5
aS'POZEN and Tribute combine to create Aralez NJBIZ - Feb 8, 2016 Aralez Pharmaceuticals Inc. announced Monday the completion of a business combination of POZEN Inc. and Tribute Pharmaceuticals Canada Inc. The company will operate under Aralez, a Canada-based global specialty pharmaceutical company with U.S.'
p6
aS'Form 8-K POZEN INC /NC For: Jul 27 StreetInsider.com - Jul 27, 2015 As part of their late-July and August non-deal roadshow in the United States and Canada , Adrian Adams, Chief Executive Officer of POZEN Inc.  and Andrew Koven, President and Chief Business Officer of POZEN,&nbsp;...'
p7
aS"Trader's Buzz: Oculus Innovative Sciences , Tobira Therapeutics (TBRA ... Wall Street Pit - Jun 8, 2015 Shares of Oculus Innovative Sciences, Inc.  are rallying, up nearly nearly 28 percent on Monday morning after it was granted FDA 510 clearance for Alevicyn SG Antipruritic Gel."
p8
aS'POZEN Appoints James P. Tursi, MD Chief Medical Officer Business Wire  - Sep 14, 2015 CHAPEL HILL, N.C.----POZEN Inc. , today announced that James P. Tursi, M.D. will be appointed Chief Medical Officer of POZEN, effective October 1, 2015.'
p9
aS'Pozen, Inc.  Reviewed By Analysts The De Soto Edge - Mar 19, 2017 Stock market analysts watching Pozen, Inc.  have recently changed their ratings on the stock. The latest reports which are outstanding on Sunday 19th of March state 0 analysts have a rating of strong buy, 0 analysts buy, 0 analysts&nbsp;...'
p10
a.